Ventas, Inc. (NYSE:VTR) EVP T Richard Riney sold 29,702 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $70.45, for a total value of $2,092,505.90. Following the transaction, the executive vice president now directly owns 163,488 shares of the company’s stock, valued at approximately $11,517,729.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of VTR traded down $0.32 during trading hours on Friday, hitting $69.12. The stock had a trading volume of 2,049,358 shares, compared to its average volume of 2,908,066. The company has a debt-to-equity ratio of 1.05, a current ratio of 0.56 and a quick ratio of 0.56. Ventas, Inc. has a 12 month low of $51.80 and a 12 month high of $73.74. The company has a market cap of $24.89 billion, a price-to-earnings ratio of 16.98, a PEG ratio of 4.53 and a beta of 0.28. The firm has a fifty day moving average price of $67.34.
Ventas (NYSE:VTR) last released its earnings results on Friday, April 26th. The real estate investment trust reported $0.99 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.96 by $0.03. The company had revenue of $942.80 million for the quarter, compared to the consensus estimate of $908.61 million. Ventas had a return on equity of 4.04% and a net margin of 12.19%. Ventas’s quarterly revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 earnings per share. As a group, analysts forecast that Ventas, Inc. will post 3.83 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Cornerstone Advisors Inc. lifted its position in Ventas by 88.9% during the first quarter. Cornerstone Advisors Inc. now owns 391 shares of the real estate investment trust’s stock valued at $25,000 after purchasing an additional 184 shares in the last quarter. Massey Quick Simon & CO. LLC purchased a new position in shares of Ventas in the first quarter valued at about $26,000. Heritage Wealth Advisors lifted its position in shares of Ventas by 59.3% in the first quarter. Heritage Wealth Advisors now owns 478 shares of the real estate investment trust’s stock valued at $31,000 after acquiring an additional 178 shares in the last quarter. Investors Research Corp purchased a new position in shares of Ventas in the first quarter valued at about $32,000. Finally, Marino Stram & Associates LLC purchased a new position in shares of Ventas in the first quarter valued at about $33,000. Institutional investors own 87.08% of the company’s stock.
A number of research firms recently weighed in on VTR. ValuEngine raised Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Friday, May 17th. Bank of America set a $300.00 price objective on IDEXX Laboratories and gave the company a “buy” rating in a research report on Friday, June 21st. Raymond James set a C$13.50 target price on Secure Energy Services and gave the stock a “strong-buy” rating in a report on Tuesday, April 30th. Morgan Stanley set a $111.00 target price on Procter & Gamble and gave the stock a “buy” rating in a report on Thursday, March 28th. Finally, Mitsubishi UFJ Financial Group lifted their target price on Ventas to $67.00 and gave the stock a “neutral” rating in a report on Wednesday, June 19th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company. Ventas has a consensus rating of “Hold” and a consensus target price of $64.82.
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.
Featured Article: What is the Bid-Ask Spread?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.